最新ニュース Absci (NASDAQ:ABSI) 株価情報

Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Equities

News

Markets

ETFs

$BTC

ABSI

ARKW

COIN

ROKU

TDOC

VERV

月曜日、Cathie Wood率いるArk Investが一連の大きな取引を行い、その中で最も注目されたのがCoinbase Global Inc.（コインベース）（NASDAQ:COIN）だった。これは、特に暗号通貨市場にとっては不穏な状況の中で行われた取引だ。今回のCOIN売買

アークインベストメント　コインベース株を売却

Absci Corp

<p>Wells Fargo  analyst Finian O'Shea   maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and lowers the price target from $21 to $19.</p>


Price Target

Analyst Ratings

HTGC

Wells Fargo Maintains Overweight on Hercules Capital, Lowers Price Target to $19

<p>Evercore ISI Group  analyst Duane Pfenningwerth   maintains Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) with a In-Line and lowers the price target from $10 to $9.</p>


Evercore ISI Group Maintains In-Line on Diamondrock Hospitality, Lowers Price Target to $9

<p>Wells Fargo  analyst Finian O'Shea   maintains Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) with a Equal-Weight and lowers the price target from $15 to $14.</p>


GBDC

Wells Fargo Maintains Equal-Weight on Golub Capital BDC, Lowers Price Target to $14

<p>Stephens &amp; Co.  analyst Russell Gunther   reiterates WSFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSFS#NASDAQ">WSFS</a>) with a Overweight and maintains $64 price target.</p>


Reiteration

WSFS

Stephens & Co. Reiterates Overweight on WSFS Financial, Maintains $64 Price Target

<p>Evercore ISI Group  analyst James Kammert   maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and lowers the price target from $23 to $21.</p>


Evercore ISI Group Maintains Outperform on Healthpeak Properties, Lowers Price Target to $21

<p>Wells Fargo  analyst Finian O'Shea   maintains Goldman Sachs BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSBD#NYSE">GSBD</a>) with a Underweight and lowers the price target from $12 to $10.</p>


GSBD

Wells Fargo Maintains Underweight on Goldman Sachs BDC, Lowers Price Target to $10

<p>Evercore ISI Group  analyst Amit Daryanani   maintains Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) with a Outperform and lowers the price target from $145 to $120.</p>


DELL

Evercore ISI Group Maintains Outperform on Dell Technologies, Lowers Price Target to $120

<p>Stephens &amp; Co.  analyst Andrew Terrell   reiterates TriCo Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBK#NASDAQ">TCBK</a>) with a Overweight and maintains $47 price target.</p>


TCBK

Stephens & Co. Reiterates Overweight on TriCo Bancshares, Maintains $47 Price Target

<p>Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Royal Caribbean Gr will report an <strong>earnings per share</strong> (EPS) of $2.53.</p>
<p>Investors in Royal Caribbean Gr are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.13, which was followed by a 1.45% increase in the share price the next day.</p>
<p>Here's a look at Royal Caribbean Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.50</td>
<td>5.03</td>
<td>2.75</td>
<td>1.33</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.63</td>
<td>5.20</td>
<td>3.21</td>
<td>1.77</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848957_0.png" alt="eps graph" /></p>
<h3>Tracking Royal Caribbean Gr's Stock Performance</h3>
<p>Shares of Royal Caribbean Gr were trading at $211.97 as of April 25. Over the last 52-week period, shares are up 56.02%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/RCL/earnings"><strong>To track all earnings releases for Royal Caribbean Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Insights Ahead: Royal Caribbean Gr's Quarterly Earnings

<p>Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Novartis to report an <strong>earnings per share</strong> (EPS) of $2.08.</p>
<p>The market awaits Novartis's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.19 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at Novartis's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.79</td>
<td>1.96</td>
<td>1.86</td>
<td>1.69</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.98</td>
<td>2.06</td>
<td>1.97</td>
<td>1.80</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848950_0.png" alt="eps graph" /></p>
<h3>Novartis Share Price Analysis</h3>
<p>Shares of Novartis were trading at $112.14 as of April 25. Over the last 52-week period, shares are up 15.69%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/NVS/earnings"><strong>To track all earnings releases for Novartis visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For Novartis

<p>BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that BP will report an <strong>earnings per share</strong> (EPS) of $0.69.</p>
<p>The market awaits BP's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.01, which was followed by a 0.38% increase in the share price the next day.</p>
<p>Here's a look at BP's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.45</td>
<td>0.76</td>
<td>0.92</td>
<td>1</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.44</td>
<td>0.83</td>
<td>1</td>
<td>0.97</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848942_0.png" alt="eps graph" /></p>
<h3>BP Share Price Analysis</h3>
<p>Shares of BP were trading at $29.19 as of April 25. Over the last 52-week period, shares are down 24.63%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BP/earnings"><strong>To track all earnings releases for BP visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For BP

<p>Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Hilton Worldwide Holdings will report an <strong>earnings per share</strong> (EPS) of $1.62.</p>
<p>The announcement from Hilton Worldwide Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.08, which was followed by a 0.26% drop in the share price the next day.</p>
<p>Here's a look at Hilton Worldwide Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.68</td>
<td>1.85</td>
<td>1.85</td>
<td>1.42</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.76</td>
<td>1.92</td>
<td>1.91</td>
<td>1.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>1.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848931_0.png" alt="eps graph" /></p>
<h3>Hilton Worldwide Holdings Share Price Analysis</h3>
<p>Shares of Hilton Worldwide Holdings were trading at $219.62 as of April 25. Over the last 52-week period, shares are up 13.44%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/HLT/earnings"><strong>To track all earnings releases for Hilton Worldwide Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Hilton Worldwide Holdings's Earnings Preview

<p>Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Sherwin-Williams to report an <strong>earnings per share</strong> (EPS) of $2.18.</p>
<p>Anticipation surrounds Sherwin-Williams's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.03, which was followed by a 2.02% drop in the share price the next day.</p>
<p>Here's a look at Sherwin-Williams's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.06</td>
<td>3.54</td>
<td>3.48</td>
<td>2.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>3.37</td>
<td>3.70</td>
<td>2.17</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>0.0%</td>
<td>-4.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848922_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Sherwin-Williams were trading at $331.62 as of April 25. Over the last 52-week period, shares are up 11.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Sherwin-Williams</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Sherwin-Williams.</p>
<p>Analysts have provided Sherwin-Williams with 11 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $387.09, suggesting a potential 16.73% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Ecolab, DuPont de Nemours and PPG Indus, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Ecolab, with an average 1-year price target of $285.71, suggesting a potential 13.84% downside.</li>
<li>Analysts currently favor an Outperform trajectory for DuPont de Nemours, with an average 1-year price target of $87.38, suggesting a potential 73.65% downside.</li>
<li>Analysts currently favor an Neutral trajectory for PPG Indus, with an average 1-year price target of $125.45, suggesting a potential 62.17% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Ecolab, DuPont de Nemours and PPG Indus, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sherwin-Williams</td>
<td>Neutral</td>
<td>0.86%</td>
<td>$2.57B</td>
<td>11.70%</td>
</tr>
<tr>
<td>Ecolab</td>
<td>Outperform</td>
<td>1.70%</td>
<td>$1.74B</td>
<td>5.47%</td>
</tr>
<tr>
<td>DuPont de Nemours</td>
<td>Outperform</td>
<td>6.69%</td>
<td>$1.12B</td>
<td>-0.50%</td>
</tr>
<tr>
<td>PPG Indus</td>
<td>Neutral</td>
<td>-7.72%</td>
<td>$755M</td>
<td>-3.84%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Sherwin-Williams ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks lower for Return on Equity. Overall, Sherwin-Williams is positioned favorably compared to its peers in terms of financial performance metrics.</p>
<h3>About Sherwin-Williams</h3>
<p>Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.</p>
<h3>Financial Insights: Sherwin-Williams</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Sherwin-Williams's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>0.86%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Sherwin-Williams's net margin is impressive, surpassing industry averages. With a net margin of <strong>9.06%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Sherwin-Williams's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.7%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Sherwin-Williams's ROA excels beyond industry benchmarks, reaching <strong>2.02%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.94</strong>, Sherwin-Williams faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/SHW/earnings"><strong>To track all earnings releases for Sherwin-Williams visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Sherwin-Williams's Upcoming Earnings

<p>Wells Fargo  analyst Finian O'Shea   maintains FS KKR Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) with a Underweight and lowers the price target from $19 to $18.</p>


Wells Fargo Maintains Underweight on FS KKR Capital, Lowers Price Target to $18

<p>Evercore ISI Group  analyst Amit Daryanani   maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Outperform and lowers the price target from $75 to $67.</p>


CSCO

Evercore ISI Group Maintains Outperform on Cisco Systems, Lowers Price Target to $67

<p>Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Altria Group to report an <strong>earnings per share</strong> (EPS) of $1.19.</p>
<p>Investors in Altria Group are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.01 in the last quarter, leading to a 1.34% increase in the share price on the following day.</p>
<p>Here's a look at Altria Group's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.28</td>
<td>1.35</td>
<td>1.34</td>
<td>1.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.29</td>
<td>1.38</td>
<td>1.31</td>
<td>1.15</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848912_0.png" alt="eps graph" /></p>
<h3>Tracking Altria Group's Stock Performance</h3>
<p>Shares of Altria Group were trading at $58.26 as of April 25. Over the last 52-week period, shares are up 33.51%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MO/earnings"><strong>To track all earnings releases for Altria Group visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Altria Group's Earnings Outlook

<p>S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect S&amp;P Global to report an <strong>earnings per share</strong> (EPS) of $4.24.</p>
<p>The announcement from S&amp;P Global is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.30, leading to a 1.67% drop in the share price the following trading session.</p>
<p>Here's a look at S&amp;P Global's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.47</td>
<td>3.64</td>
<td>3.54</td>
<td>3.66</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.77</td>
<td>3.89</td>
<td>4.04</td>
<td>4.01</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848905_0.png" alt="eps graph" /></p>
<h3>S&amp;P Global Share Price Analysis</h3>
<p>Shares of S&amp;P Global were trading at $480.0 as of April 25. Over the last 52-week period, shares are up 15.91%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analysts' Take on S&amp;P Global</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on S&amp;P Global.</p>
<p>The consensus rating for S&amp;P Global is Outperform, based on 8 analyst ratings. With an average one-year price target of $605.25, there's a potential 26.09% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of CME Group, Intercontinental Exchange and Moodys, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for CME Group, with an average 1-year price target of $266.18, suggesting a potential 44.55% downside.</li>
<li>Analysts currently favor an Buy trajectory for Intercontinental Exchange, with an average 1-year price target of $200.0, suggesting a potential 58.33% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Moodys, with an average 1-year price target of $513.82, suggesting a potential 7.05% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for CME Group, Intercontinental Exchange and Moodys are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>S&amp;P Global</td>
<td>Outperform</td>
<td>13.96%</td>
<td>$2.48B</td>
<td>2.62%</td>
</tr>
<tr>
<td>CME Group</td>
<td>Neutral</td>
<td>7.67%</td>
<td>$1.30B</td>
<td>3.53%</td>
</tr>
<tr>
<td>Intercontinental Exchange</td>
<td>Buy</td>
<td>13.65%</td>
<td>$1.62B</td>
<td>2.54%</td>
</tr>
<tr>
<td>Moodys</td>
<td>Neutral</td>
<td>7.73%</td>
<td>$1.43B</td>
<td>17.21%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>S&amp;P Global ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on Equity. Overall, S&amp;P Global is positioned well compared to its peers in terms of financial performance metrics.</p>
<h3>Unveiling the Story Behind S&amp;P Global</h3>
<p>S&amp;P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&amp;P's largest segment by profitability. S&amp;P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&amp;P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.</p>
<h3>S&amp;P Global: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> S&amp;P Global displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>13.96%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> S&amp;P Global's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>24.5%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> S&amp;P Global's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>2.62%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>1.46%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> S&amp;P Global's debt-to-equity ratio is below the industry average. With a ratio of <b>0.36</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/SPGI/earnings"><strong>To track all earnings releases for S&amp;P Global visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SPGI

Earnings Preview: S&P Global

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Advanced Micro Devices</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMD, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Advanced Micro Devices.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 26% bullish and 53%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $429,598, and 8 are calls, for a total amount of $1,198,255.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $145.0 for Advanced Micro Devices over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Advanced Micro Devices's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Advanced Micro Devices's substantial trades, within a strike price spectrum from $90.0 to $145.0 over the preceding 30 days.</p>
<h3>Advanced Micro Devices Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848900_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.6</td>
<td>$95.00</td>
<td>$942.7K</td>
<td>4.4K</td>
<td align="right">627</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$16.35</td>
<td>$16.25</td>
<td>$16.34</td>
<td>$110.00</td>
<td>$104.4K</td>
<td>24.6K</td>
<td align="right">64</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$7.75</td>
<td>$7.65</td>
<td>$7.67</td>
<td>$100.00</td>
<td>$90.8K</td>
<td>23.9K</td>
<td align="right">346</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.65</td>
<td>$15.55</td>
<td>$15.62</td>
<td>$110.00</td>
<td>$60.9K</td>
<td>24.6K</td>
<td align="right">191</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.7</td>
<td>$7.65</td>
<td>$7.72</td>
<td>$100.00</td>
<td>$58.5K</td>
<td>23.9K</td>
<td align="right">145</td>
</tr>
</tbody>
</table>
</p>
<h3>About Advanced Micro Devices</h3>
<p>Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.</p>
<p>In light of the recent options history for Advanced Micro Devices, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Advanced Micro Devices</h3>
<ul>
<li>Currently trading with a volume of 3,010,677, the AMD's price is up by 0.73%, now at $97.35. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 8 days.</li>
</ul>
<h3>Professional Analyst Ratings for Advanced Micro Devices</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $121.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wedbush keeps a Outperform rating on Advanced Micro Devices with a target price of $115.<br />
&#x2A; Consistent in their evaluation, an analyst from Susquehanna keeps a Positive rating on Advanced Micro Devices with a target price of $135.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Advanced Micro Devices, targeting a price of $110.<br />
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on Advanced Micro Devices with a target price of $126.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Advanced Micro Devices with a target price of $120. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Advanced Micro Devices, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

What the Options Market Tells Us About Advanced Micro Devices

<p>Deep-pocketed investors have adopted a bullish approach towards Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GOOGL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Alphabet. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 70% leaning bullish and 30% bearish. Among these notable options, 2 are puts, totaling $65,400, and 8 are calls, amounting to $386,202.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $155.0 and $190.0 for Alphabet, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Alphabet's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Alphabet's significant trades, within a strike price range of $155.0 to $190.0, over the past month.</p>
<h3>Alphabet Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848895_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$6.3</td>
<td>$6.25</td>
<td>$6.3</td>
<td>$170.00</td>
<td>$92.6K</td>
<td>8.0K</td>
<td align="right">210</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$14.9</td>
<td>$14.8</td>
<td>$14.8</td>
<td>$170.00</td>
<td>$59.2K</td>
<td>7.5K</td>
<td align="right">0</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$4.6</td>
<td>$4.55</td>
<td>$4.6</td>
<td>$170.00</td>
<td>$53.2K</td>
<td>20.6K</td>
<td align="right">120</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$6.35</td>
<td>$6.25</td>
<td>$6.35</td>
<td>$170.00</td>
<td>$40.0K</td>
<td>8.0K</td>
<td align="right">0</td>
</tr>
<tr>
<td>GOOGL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$160.00</td>
<td>$39.2K</td>
<td>10.9K</td>
<td align="right">174</td>
</tr>
</tbody>
</table>
</p>
<h3>About Alphabet</h3>
<p>Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.</p>
<p>In light of the recent options history for Alphabet, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Alphabet</h3>
<ul>
<li>With a trading volume of 4,323,557, the price of GOOGL is down by -0.12%, reaching $161.77.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 85 days from now.</li>
</ul>
<h3>Expert Opinions on Alphabet</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $189.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Rosenblatt has decided to maintain their Neutral rating on Alphabet, which currently sits at a price target of $189.<br />
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Alphabet, targeting a price of $185.<br />
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Alphabet with a target price of $195.<br />
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on Alphabet, which currently sits at a price target of $200.<br />
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $178. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Alphabet, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


GOOGL

Alphabet's Options: A Look at What the Big Money is Thinking

<p>Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Visa will report an <strong>earnings per share</strong> (EPS) of $2.68.</p>
<p>The market awaits Visa's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS beat by $0.09, leading to a 0.36% drop in the share price on the subsequent day.</p>
<p>Here's a look at Visa's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.66</td>
<td>2.58</td>
<td>2.42</td>
<td>2.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.75</td>
<td>2.71</td>
<td>2.42</td>
<td>2.51</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>3.0%</td>
<td>-4.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745848893_0.png" alt="eps graph" /></p>
<h3>Market Performance of Visa's Stock</h3>
<p>Shares of Visa were trading at $335.17 as of April 25. Over the last 52-week period, shares are up 26.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Visa</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Visa.</p>
<p>Analysts have provided Visa with 16 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $383.5, suggesting a potential 14.42% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Mastercard, Fiserv and PayPal Holdings, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Mastercard, with an average 1-year price target of $640.6, suggesting a potential 91.13% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Fiserv, with an average 1-year price target of $256.5, suggesting a potential 23.47% downside.</li>
<li>Analysts currently favor an Neutral trajectory for PayPal Holdings, with an average 1-year price target of $84.13, suggesting a potential 74.9% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Mastercard, Fiserv and PayPal Holdings are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Visa</td>
<td>Outperform</td>
<td>10.15%</td>
<td>$7.49B</td>
<td>13.56%</td>
</tr>
<tr>
<td>Mastercard</td>
<td>Outperform</td>
<td>14.37%</td>
<td>$5.84B</td>
<td>48.00%</td>
</tr>
<tr>
<td>Fiserv</td>
<td>Outperform</td>
<td>-2.30%</td>
<td>$3.23B</td>
<td>3.21%</td>
</tr>
<tr>
<td>PayPal Holdings</td>
<td>Neutral</td>
<td>4.24%</td>
<td>$3.94B</td>
<td>5.52%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Visa ranks at the top for Gross Profit and Revenue Growth among its peers. It is in the middle for Return on Equity. The company with the highest Return on Equity has the lowest Revenue Growth. The company with the lowest Gross Profit has a negative Revenue Growth.</p>
<h3>All You Need to Know About Visa</h3>
<p>Visa is the largest payment processor in the world. In fiscal 2023, it processed almost $15 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.</p>
<h3>Understanding the Numbers: Visa's Finances</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Visa displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>10.15%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Visa's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>53.83%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Visa's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>13.56%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Visa's ROA excels beyond industry benchmarks, reaching <strong>5.49%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.55</strong>, Visa adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/V/earnings"><strong>To track all earnings releases for Visa visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Visa

Small Cap

Opinion

Press Releases

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Health Care

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Participate in Upcoming Investor Conferences

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

AVAI

BFLY

GEHC

MDAI

RXRX

TREN

Abivax

Altimmune

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Checkpoint Therapeutics, Inc. - Common Stock

Checkpoint Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Erasca

Kura Oncology

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Regenxbio

Sage Therapeutics

Sana Biotechnology

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Upstream Bio

Verve Therapeutics

Verastem

Keybanc

Needham

Guggenheim

HC Wainwright & Co.

Morgan Stanley

<p>月曜日、<strong>Cathie Wood</strong>率いる<strong>Ark Invest</strong>が一連の大きな取引を行い、その中で最も注目されたのが<strong>Coinbase Global Inc.（コインベース）</strong>（NASDAQ:COIN）だった。これは、特に暗号通貨市場にとっては不穏な状況の中で行われた取引だ。</p>
<p><strong>今回のCOIN売買</strong></p>
<p>Ark Investのこの日最も顕著な取引は、最大手暗号通貨取引プラットフォームであるCoinbaseとのものだ。この取引は、<strong>ビットコイン</strong>（CRYPTO:BTC）の価格が6万2,000ドルを割り込んだというタイミングで行われたもので、<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39459091/coinbase-shares-tumble-with-bitcoin-whats-going-on-with-the-stock">暗号通貨市場がかなりの揺れを体験している</a>状況でのものだ。このビットコイン価格の下落はCoinbase株に直接的な影響を与え、同社の株価も月曜日、前週末の取引で下げてしまった。</p>
<p>月曜日の取引の最後にCoinbase株は212.31ドルで推移していた。同社は、<strong> ARK Next Generation Internet ETF</strong>（NYSE:ARKW）を通じて3,341株のCoinbase株を売却。この取引は709,327ドルに相当する。</p>
<p><strong>その他の注目すべき取引</strong></p>
<p><em>関連記事：『ドージコインキラー』Shiba Inu、悪化-短期的な将来の見通しについて示す主要指標<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39448955/dogecoin-killer-shiba-inu-falters-here-is-what-these-key-indicators-reveal-about-its-short?itm_source=parsely-api" target="_blank" rel="noopener noreferrer">リンク</a> </em></p>
<ul>
<li><strong>Teladoc Health Inc</strong>（NYSE:TDOC）：ARKG ETF から54,256株、ARKK ETFから61,606株の売却。</li>
<li><strong>Absci Corp</strong>（NASDAQ:ABSI）：ARKG ETF に43,936株の取得。</li>
<li><strong>Verve Therapeutics Inc</strong>（NASDAQ:VERV）：ARKG ETF から10,570株、ARKK ETF から50,971株の売却。</li>
<li><strong>Roku Inc</strong>（NASDAQ:ROKU）：ARKK ETF に32,989株の取得。</li>
</ul>
<p><em>次の記事を読む: ビットコイン、イーサリアム、ドージコインが投資家の懸念で下落- 60,000ドルまでの激しい下げ<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39448829/bitcoin-ethereum-dogecoin-fall-on-investor-worries-analyst-warns-of-king-cryptos-dip-below?itm_source=parsely-api" target="_blank" rel="noopener noreferrer">リンク</a> </em></p>
<p>本記事は <a href="https://www.benzinga.com/author/benzinga-neuro"> Benzinga Neuro </a>によって生成され、<u><a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noopener noreferrer"> Shivdeep Dhaliwal</a></u>によって編集されました。</p>

Comments

Absci

ニュース

最新ニュース Absci (NASDAQ:ABSI) 株価情報

火曜日, 6 25, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル